Possibia

3241147

Last Update Posted: 2019-09-30

Recruiting has ended

All Genders

accepted

18 Years-70 Years

23 Estimated Participants

No Expanded Access

Interventional Study

Accepts healthy volunteers

Pharmacokinetics of Lu AF35700 in Subjects With Renal Impairment

This study will evaluate the pharmacokinetics of Lu AF35700 after a single dose tablet to subjects with renal impairment (kidney insufficiency) and compare that with healthy subjects

If the initial data shows a substantial effect in subjects with severe renal impairment, the study will be expanded to include subjects with intermediate level (mild and moderate) of renal impairment.

Eligibility

Relevant conditions:

Renal Failure

If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.

locations

Contact Information

Overall Contact

No valid contacts available

Data sourced from ClinicalTrials.gov